These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23812530)

  • 21. A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
    Márquez G; Herrera-Acosta E; Vidal I; Galvany L; Iglesias M; Umbert P
    Int J Dermatol; 2009 Jan; 48(1):97-8. PubMed ID: 19126063
    [No Abstract]   [Full Text] [Related]  

  • 22. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
    Saif MW; Gnanaraj J
    Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome.
    Baccard M; Morel P
    Cutis; 1994 Feb; 53(2):83-4. PubMed ID: 7851127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertrichosis lanuginosa acquisita associated with autoimmune hepatitis.
    Roh MR; Chung HJ; Cho YH; Chung KY
    J Dermatol; 2006 Aug; 33(8):574-6. PubMed ID: 16923142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired trichomegaly and hypertrichosis].
    Aerts L; Lauwers N; Smets RM
    J Fr Ophtalmol; 2014 Apr; 37(4):339-41. PubMed ID: 24576565
    [No Abstract]   [Full Text] [Related]  

  • 26. Idiopathic, acquired, localised and transient trichomegaly.
    Samia-Aly E; Mellington F
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33727305
    [No Abstract]   [Full Text] [Related]  

  • 27. Eyelash Trichomegaly: Unusual Feature Associated with Systemic Lupus Erythematosus Patient.
    AlWarawreh AM; AlWarawreh AM; Jarrar BF; Aldebei AH; Ajarmeh MS; Ayyash FF; Abu Al-Ghanam MA
    Case Rep Med; 2022; 2022():1320992. PubMed ID: 35968264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).
    Foerster CG; Cursiefen C; Kruse FE
    Cornea; 2008 Jun; 27(5):612-4. PubMed ID: 18520515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
    Johnstone MA
    Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
    Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN
    J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793
    [No Abstract]   [Full Text] [Related]  

  • 31. Trichomegaly induced by erlotinib.
    Papadopoulos R; Chasapi V; Bachariou A
    Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive trichomegaly.
    Vano-Galvan S; Moreno-Martin P; Jaén P
    Neth J Med; 2009 Jan; 67(1):35-6. PubMed ID: 19155549
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired trichomegaly with topiramate.
    Santmyire-Rosenberger BR; Albert M
    J Am Acad Dermatol; 2005 Aug; 53(2):362-3. PubMed ID: 16021148
    [No Abstract]   [Full Text] [Related]  

  • 34. Trichomegaly Induced by Cetuximab: Case Series and Review the Literature.
    Koksal UI; Pilanci KN; Ordu C; Okutur K; Saglam S; Demir G
    Am J Ther; 2016; 23(5):e1226-9. PubMed ID: 26079631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichomegaly Associated with Panitumumab.
    Goyal A; Blaes A
    N Engl J Med; 2020 Oct; 383(16):e94. PubMed ID: 33053288
    [No Abstract]   [Full Text] [Related]  

  • 36. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
    Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
    Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired hypertrichosis of the eyelashes in AIDS].
    Janier M; Oksenhendler E; Civatte J
    Ann Dermatol Venereol; 1989; 116(8):559-61. PubMed ID: 2596800
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acquired hypertrichosis of eyelashes in AIDS].
    Poizot-Martin I; Lafeuillade A; Gourgeonnet A; Dhiver C; Gamby T; Gastaut JA
    Ann Dermatol Venereol; 1992; 119(2):143-4. PubMed ID: 1605514
    [No Abstract]   [Full Text] [Related]  

  • 39. Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.
    Bambury R; McCaffrey JA
    Clin Colorectal Cancer; 2009 Oct; 8(4):235. PubMed ID: 19822516
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
    Zhang G; Basti S; Jampol LM
    Cornea; 2007 Aug; 26(7):858-60. PubMed ID: 17667622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.